Expanding Care for Young Patients Managing ulcerative colitis as a child or teenager presents unique challenges. Recently, the medical community reached a significant milestone in pediatric care. The FDA has officially approved Stelara (ustekinumab) for the treatment of pediatric patients aged 6 years and older who are suffering from moderately to severely active ulcerative colitis.…